Performance guarantees for individualized treatment rules
From MaRDI portal
Publication:548554
DOI10.1214/10-AOS864zbMath1216.62178arXiv1105.3369OpenAlexW3106017199WikidataQ42748821 ScholiaQ42748821MaRDI QIDQ548554
Publication date: 29 June 2011
Published in: The Annals of Statistics (Search for Journal in Brave)
Full work available at URL: https://arxiv.org/abs/1105.3369
Multivariate analysis (62H99) Applications of statistics to biology and medical sciences; meta analysis (62P10) Medical applications (general) (92C50) Statistical decision theory (62C99) Estimation in survival analysis and censored data (62N02)
Related Items (only showing first 100 items - show all)
Deep advantage learning for optimal dynamic treatment regime ⋮ Personalised treatment assignment maximising expected benefit with smooth hinge loss ⋮ Treatment recommendation and parameter estimation under single-index contrast function ⋮ D-learning to estimate optimal individual treatment rules ⋮ A Semiparametric Approach to Model Effect Modification ⋮ Greedy outcome weighted tree learning of optimal personalized treatment rules ⋮ Data-guided Treatment Recommendation with Feature Scores ⋮ Statistical inference for the mean outcome under a possibly non-unique optimal treatment strategy ⋮ A rank-based approach to estimating monotone individualized two treatment regimes ⋮ Subgroup identification and variable selection for treatment decision making ⋮ Estimating individualized treatment rules for treatments with hierarchical structure ⋮ Multiple Domain and Multiple Kernel Outcome-Weighted Learning for Estimating Individualized Treatment Regimes ⋮ Identifying optimal biomarker combinations for treatment selection via a robust kernel method ⋮ High-dimensional \(A\)-learning for optimal dynamic treatment regimes ⋮ Augmented direct learning for conditional average treatment effect estimation with double robustness ⋮ Functional Feature Construction for Individualized Treatment Regimes ⋮ Quantile-Optimal Treatment Regimes ⋮ High-dimensional inference for personalized treatment decision ⋮ Evaluating marker-guided treatment selection strategies ⋮ Combining biomarkers to optimize patient treatment recommendations ⋮ Optimal designs for dose-response models with linear effects of covariates ⋮ Concordance and value information criteria for optimal treatment decision ⋮ Multi-response based personalized treatment selection with data from crossover designs for multiple treatments ⋮ A Single-Index Model With a Surface-Link for Optimizing Individualized Dose Rules ⋮ Min-Max Optimal Design of Two-Armed Trials with Side Information ⋮ Estimation of Optimal Individualized Treatment Rules Using a Covariate-Specific Treatment Effect Curve With High-Dimensional Covariates ⋮ A Two-Part Framework for Estimating Individualized Treatment Rules From Semicontinuous Outcomes ⋮ Nonparametric Estimation of Conditional Expectation with Auxiliary Information and Dimension Reduction ⋮ High-Dimensional Precision Medicine From Patient-Derived Xenografts ⋮ On using electronic health records to improve optimal treatment rules in randomized trials ⋮ Estimating individualized treatment rules with risk constraint ⋮ Adaptive treatment and robust control ⋮ Optimal designs for the development of personalized treatment rules ⋮ Identifying individual predictive factors for treatment efficacy ⋮ On estimating optimal regime for treatment initiation time based on restricted mean residual lifetime ⋮ Discussion of ``Dynamic treatment regimes: technical challenges and applications ⋮ Rejoinder of ``Dynamic treatment regimes: technical challenges and applications ⋮ Dynamic Causal Effects Evaluation in A/B Testing with a Reinforcement Learning Framework ⋮ On Robustness of Individualized Decision Rules ⋮ Net benefit index: Assessing the influence of a biomarker for individualized treatment rules ⋮ Estimating the optimal individualized treatment rule from a cost‐effectiveness perspective ⋮ Functional additive models for optimizing individualized treatment rules ⋮ Model-Assisted Uniformly Honest Inference for Optimal Treatment Regimes in High Dimension ⋮ Individualized Group Learning ⋮ Personalized treatment selection using observational data ⋮ A Sparse Random Projection-Based Test for Overall Qualitative Treatment Effects ⋮ iFusion: Individualized Fusion Learning ⋮ Resampling‐based confidence intervals for model‐free robust inference on optimal treatment regimes ⋮ A constrained single‐index regression for estimating interactions between a treatment and covariates ⋮ Multi-Armed Angle-Based Direct Learning for Estimating Optimal Individualized Treatment Rules With Various Outcomes ⋮ Variable selection for estimating the optimal treatment regimes in the presence of a large number of covariates ⋮ Performance guarantees for policy learning ⋮ Matched Learning for Optimizing Individualized Treatment Strategies Using Electronic Health Records ⋮ Towards Min Max Generalization in Reinforcement Learning ⋮ A Sequential Significance Test for Treatment by Covariate Interactions ⋮ Unnamed Item ⋮ On a necessary and sufficient identification condition of optimal treatment regimes with an instrumental variable ⋮ A Robust Method for Estimating Optimal Treatment Regimes ⋮ Diagnosis-group-specific transitional care program recommendations for 30-day rehospitalization reduction ⋮ The use of covariates and random effects in evaluating predictive biomarkers under a potential outcome framework ⋮ Performance guarantees for individualized treatment rules ⋮ Unnamed Item ⋮ Experimental Evaluation of Individualized Treatment Rules ⋮ Learning Optimal Personalized Treatment Rules in Consideration of Benefit and Risk: With an Application to Treating Type 2 Diabetes Patients With Insulin Therapies ⋮ A single-index model with multiple-links ⋮ COMBINING ESTIMATES OF CONDITIONAL TREATMENT EFFECTS ⋮ Regularized outcome weighted subgroup identification for differential treatment effects ⋮ Estimating treatment effect heterogeneity in randomized program evaluation ⋮ Sequential Advantage Selection for Optimal Treatment Regimes ⋮ Treatment decisions based on scalar and functional baseline covariates ⋮ Using decision lists to construct interpretable and parsimonious treatment regimes ⋮ A Simple Method for Estimating Interactions Between a Treatment and a Large Number of Covariates ⋮ An Algorithm for Generating Individualized Treatment Decision Trees and Random Forests ⋮ A predictive enrichment procedure to identify potential responders to a new therapy for randomized, comparative controlled clinical studies ⋮ On testing conditional qualitative treatment effects ⋮ Estimation of Individualized Decision Rules Based on an Optimized Covariate-Dependent Equivalent of Random Outcomes ⋮ Fused comparative intervention scoring for heterogeneity of longitudinal intervention effects ⋮ Proper Inference for Value Function in High-Dimensional Q-Learning for Dynamic Treatment Regimes ⋮ More Efficient Policy Learning via Optimal Retargeting ⋮ Learning Optimal Distributionally Robust Individualized Treatment Rules ⋮ Discussion of Kallus (2020) and Mo et al. (2020) ⋮ Unnamed Item ⋮ Unnamed Item ⋮ Incorporating Patient Preferences into Estimation of Optimal Individualized Treatment Rules ⋮ Interpretable Dynamic Treatment Regimes ⋮ Generalization error bounds of dynamic treatment regimes in penalized regression-based learning ⋮ A Semiparametric Instrumental Variable Approach to Optimal Treatment Regimes Under Endogeneity ⋮ Learning Individualized Treatment Rules for Multiple-Domain Latent Outcomes ⋮ Stochastic Tree Search for Estimating Optimal Dynamic Treatment Regimes ⋮ Optimal Individualized Decision Rules Using Instrumental Variable Methods ⋮ Rejoinder: Optimal Individualized Decision Rules Using Instrumental Variable Methods ⋮ Improved Doubly Robust Estimation in Learning Optimal Individualized Treatment Rules ⋮ Selecting and Ranking Individualized Treatment Rules With Unmeasured Confounding ⋮ Personalized Policy Learning Using Longitudinal Mobile Health Data ⋮ Unnamed Item ⋮ Unnamed Item ⋮ Focused information criterion on predictive models in personalized medicine ⋮ Optimal designs for semi-parametric dose-response models under random contamination ⋮ Estimating Individualized Treatment Rules Using Outcome Weighted Learning ⋮ Constrained optimization for stratified treatment rules in reducing hospital readmission rates of diabetic patients
Cites Work
- Unnamed Item
- Unnamed Item
- Unnamed Item
- Unnamed Item
- The Adaptive Lasso and Its Oracle Properties
- Performance guarantees for individualized treatment rules
- Evaluating subject-level incremental values of new markers for risk classification rule
- Sparsity in penalized empirical risk minimization
- The sparsity and bias of the LASSO selection in high-dimensional linear regression
- Smooth discrimination analysis
- Optimal aggregation of classifiers in statistical learning.
- Measuring mass concentrations and estimating density contour clusters -- An excess mass approach
- Simultaneous analysis of Lasso and Dantzig selector
- High-dimensional generalized linear models and the lasso
- Sparsity oracle inequalities for the Lasso
- Estimation of Survival Distributions of Treatment Policies in Two-Stage Randomization Designs in Clinical Trials
- History-Adjusted Marginal Structural Models and Statically-Optimal Dynamic Treatment Regimens
- Calibrating parametric subject-specific risk estimation
- FAST RATES FOR ESTIMATION ERROR AND ORACLE INEQUALITIES FOR MODEL SELECTION
- Ideal spatial adaptation by wavelet shrinkage
- Variable Selection via Nonconcave Penalized Likelihood and its Oracle Properties
- Marginal Mean Models for Dynamic Regimes
- Selecting Therapeutic Strategies Based on Efficacy and Death in Multicourse Clinical Trials
- Optimal Dynamic Treatment Regimes
- Optimal Structural Nested Models for Optimal Sequential Decisions
- Semiparametric efficient estimation of survival distributions in two-stage randomisation designs in clinical trials with censored data
- Convexity, Classification, and Risk Bounds
This page was built for publication: Performance guarantees for individualized treatment rules